Alan Fogelman, M.D.

A Short Biography:

Dr. Alan M Fogelman graduated from the University of California Los Angeles David Geffen School of Medicine. He is the current Executive of the Department of Medicine and and the Director or the Atherosclerosis Research Unit at the David Geffen School of Medicine. His research interests include cell biology of the artery wall and lipid metabolism, growth factors, anc endothelium.

Work Titles
CTSI Member, Internal Advisory Board Member, CTSI
UCLA Chair, Medicine Director, Atherosclerosis Research Unit Professor, Medicine Member, Cardiology
Education:
Degrees:
M.D., University of California, Los Angeles, 1962 - 1966
B.S., University of California, Los Angeles, 1962
Fellowship:
1971 - 1973 UCLA School of Medicine
Internship:
1966 - 1967 UCLA School of Medicine
Residency:
1970 - 1971 UCLA School of Medicine
1967 - 1968 UCLA School of Medicine
Certifications:
Certifications:
1975 American Board of Internal Medicine
1972 American Board of Internal Medicine

Contact Information:

Work Phone Number:

(310) 825-6058

Office Address:

Office Address
10833 Le Conte Ave.
37-120 CHS
Los Angeles, CA 90095


Publications:

A selected list of publications:

Chattopadhyay Arnab, Navab Mohamad, Hough Greg, Gao Feng, Meriwether David, Grijalva Victor, Springstead James R, Palgnachari Mayakonda N, Namiri-Kalantari Ryan, Su Feng, Van Lenten Brian J, Wagner Alan C, Anantharamaiah G M, Farias-Eisener Robin, Reddy Srinivasa T, Fogelman Alan M   A novel approach to oral apoA-I mimetic therapy Journal of lipid research, 2013; 54(4): 995-1010.
Li Rongsong, Navab Mohamad, Pakbin Payam, Ning Zhi, Navab Kaveh, Hough Greg, Morgan Todd E, Finch Caleb E, Araujo Jesus A, Fogelman Alan M, Sioutas Constantinos, Hsiai Tzung   Ambient Ultrafine Particles Alter Lipid Metabolism and HDL Anti-Oxidant Capacity in LDLR-null Mice Journal of lipid research, 2013; .
Yin Fen, Lawal Akeem, Ricks Jerry, Fox Julie R, Larson Tim, Navab Mohamad, Fogelman Alan M, Rosenfeld Michael E, Araujo Jesus A   Diesel Exhaust Induces Systemic Lipid Peroxidation and Development of Dysfunctional Pro-Oxidant and Proinflammatory High-Density Lipoprotein Arteriosclerosis, thrombosis, and vascular biology, 2013; .
Gao Feng, Chattopadhyay Arnab, Navab Mohamad, Grijalva Victor, Su Feng, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1? in human ovarian cancer cell lines and a mouse ovarian cancer model The Journal of pharmacology and experimental therapeutics, 2012; 342(2): 255-62.
Ganapathy Ekambaram, Su Feng, Meriwether David, Devarajan Asokan, Grijalva Victor, Gao Feng, Chattopadhyay Arnab, Anantharamaiah G M, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD International journal of cancer. Journal international du cancer, 2012; 130(5): 1071-81.
Navab Mohamad, Reddy Srinivasa T, Anantharamaiah G M, Hough Greg, Buga Georgette M, Danciger Jan, Fogelman Alan M   D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice Journal of lipid research, 2012; 53(3): 437-45.
Kelesidis Theodoros, Reddy Srinivasa T, Huynh Diana, Meriwether David, Fogelman Alan M, Navab Mohamad, Yang Otto O   Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity Lipids in health and disease, 2012; 11(2): 87.
Su Feng, Grijalva Victor, Navab Kaveh, Ganapathy Ekambaram, Meriwether David, Imaizumi Satoshi, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer Molecular cancer therapeutics, 2012; 53(6): .
Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Buga Georgette M, Hough Greg, Wagner Alan C, Fogelman Alan M   High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature Arteriosclerosis, thrombosis, and vascular biology, 2012; 32(11): 2553-60.
Hong Cynthia, Bradley Michele N, Rong Xin, Wang Xuping, Wagner Alan, Grijalva Victor, Castellani Lawrence W, Salazar Jon, Realegeno Susan, Boyadjian Rima, Fogelman Alan M, Van Lenten Brian J, Reddy Srinivasa T, Lusis Aldons J, Tangirala Rajendra K, Tontonoz Peter   LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice Journal of lipid research, 2012; 53(6): 1126-33.
Kelesidis Theodoros, Currier Judith S, Huynh Diana, Meriwether David, Charles-Schoeman Christina, Reddy Srinivasa T, Fogelman Alan M, Navab Mohamad, Yang Otto O   A biochemical fluorometric method for assessing the oxidative properties of HDL Journal of lipid research, 2011; 52(12): 2341-51.
Morgantini Cecilia, Natali Andrea, Boldrini Beatrice, Imaizumi Satoshi, Navab Mohamad, Fogelman Alan M, Ferrannini Ele, Reddy Srinivasa T   Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes, 2011; 60(10): 2617-23.
Imaizumi Satoshi, Navab Mohamad, Morgantini Cecilia, Charles-Schoeman Christina, Su Feng, Gao Feng, Kwon Murray, Ganapathy Ekambaram, Meriwether David, Farias-Eisner Robin, Fogelman Alan M, Reddy Srinivasa T   Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins Circulation journal : official journal of the Japanese Circulation Society, 2011; 75(7): 1533-8.
Meriwether David, Imaizumi Satoshi, Grijalva Victor, Hough Greg, Vakili Ladan, Anantharamaiah G M, Farias-Eisner Robin, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Shechter Ishaiahu   Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma Journal of lipid research, 2011; 52(10): 1795-809.
Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nature reviews. Cardiology, 2011; 8(4): 222-32.
Kelesidis Theodoros, Yang Otto O, Currier Judith S, Navab Kaveh, Fogelman Alan M, Navab Mohamad   HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL Lipids in health and disease, 2011; 10(4): 35.
Navab Mohamad, Reddy Srinivasa T, Anantharamaiah G M, Imaizumi Satoshi, Hough Greg, Hama Susan, Fogelman Alan M   Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally Journal of lipid research, 2011; 52(6): 1200-10.
Gao Feng, Vasquez Sergio X, Su Feng, Roberts Svetlana, Shah Neha, Grijalva Victor, Imaizumi Satoshi, Chattopadhyay Arnab, Ganapathy Ekambaram, Meriwether David, Johnston Brad, Anantharamaiah G M, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways Integrative biology : quantitative biosciences from nano to macro, 2011; 3(4): 479-89.
Besler Christian, Heinrich Kathrin, Rohrer Lucia, Doerries Carola, Riwanto Meliana, Shih Diana M, Chroni Angeliki, Yonekawa Keiko, Stein Sokrates, Schaefer Nicola, Mueller Maja, Akhmedov Alexander, Daniil Georgios, Manes Costantina, Templin Christian, Wyss Christophe, Maier Willibald, Tanner Felix C, Matter Christian M, Corti Roberto, Furlong Clement, Lusis Aldons J, von Eckardstein Arnold, Fogelman Alan M, Lüscher Thomas F, Landmesser Ulf   Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease The Journal of clinical investigation, 2011; 121(7): 2693-708.
Vaziri Nosratola D, Navab Kaveh, Gollapudi Pavan, Moradi Hamid, Pahl Madeleine V, Barton Cyril H, Fogelman Alan M, Navab Mohamad   Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease Journal of the National Medical Association, 2011; 103(6): 524-33.
Watson Catherine E, Weissbach Nicole, Kjems Lise, Ayalasomayajula Surya, Zhang Yiming, Chang Ih, Navab Mohamad, Hama Susan, Hough Greg, Reddy Srinivasa T, Soffer Daniel, Rader Daniel J, Fogelman Alan M, Schecter Alison   Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function Journal of lipid research, 2011; 52(2): 361-73.
Vaziri Nosratola D, Kim Hyun Ju, Moradi Hamid, Farmand Farbod, Navab Kaveh, Navab Mohamad, Hama Susan, Fogelman Alan M, Quiroz Yasmir, Rodriguez-Iturbe Bernardo   Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010; 25(11): 3525-34.
Su Feng, Kozak Kathy R, Imaizumi Satoshi, Gao Feng, Amneus Malaika W, Grijalva Victor, Ng Carey, Wagner Alan, Hough Greg, Farias-Eisner Gina, Anantharamaiah G M, Van Lenten Brian J, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T, Farias-Eisner Robin   Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer Proceedings of the National Academy of Sciences of the United States of America, 2010; 107(46): 19997-20002.
Morgantini Cecilia, Imaizumi Satoshi, Grijalva Victor, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes Diabetes, 2010; 59(12): 3223-8.
Vaziri Nosratola D, Navab Mohamad, Fogelman Alan M   HDL metabolism and activity in chronic kidney disease Nature reviews. Nephrology, 2010; 6(5): 287-96.
Imaizumi Satoshi, Grijalva Victor, Navab Mohamad, Van Lenten Brian J, Wagner Alan C, Anantharamiah G M, Fogelman Alan M, Reddy Srinivasa T   L-4F Differentially Alters Plasma Levels of Oxidized Fatty Acids Resulting in More Anti-inflammatory HDL in Mice Drug metabolism letters, 2010; 4(3): .
Buga Georgette M, Navab Mohamad, Imaizumi Satoshi, Reddy Srinivasa T, Yekta Babak, Hough Greg, Chanslor Shawn, Anantharamaiah G M, Fogelman Alan M   L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation Arteriosclerosis, thrombosis, and vascular biology, 2010; 30(2): 283-9.
Imaizumi Satoshi, Grijalva Victor, Navab Mohamad, Van Lenten Brian J, Wagner Alan C, Anantharamiah G M, Fogelman Alan M, Reddy Srinivasa T   L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice Drug metabolism letters, 2010; 4(3): 139-48.
Imaizumi Satoshi, Grijalva Victor, Priceman Saul, Wu Lily, Su Feng, Farias-Eisner Robin, Hama Susan, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels Molecular genetics and metabolism, 2010; 101(1): 66-75.
Ruchala Piotr, Navab Mohamad, Jung Chun-Ling, Hama-Levy Susan, Micewicz Ewa D, Luong Hai, Reyles Jonathan E, Sharma Shantanu, Waring Alan J, Fogelman Alan M, Lehrer Robert I   Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids PloS one, 2010; 5(4): e10181.
Navab Mohamad, Shechter Ishaiahu, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   Structure and function of HDL mimetics Arteriosclerosis, thrombosis, and vascular biology, 2010; 30(2): 164-8.
Fogelman Alan M   The complexity of high-density lipoproteins Circulation, 2010; 122(19): 1900-1.
Woo Jennifer M P, Lin Zhuofeng, Navab Mohamad, Van Dyck Casey, Trejo-Lopez Yvette, Woo Krystal M T, Li Hongyun, Castellani Lawrence W, Wang Xuping, Iikuni Noriko, Rullo Ornella J, Wu Hui, La Cava Antonio, Fogelman Alan M, Lusis Aldons J, Tsao Betty P   Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis Arthritis research & therapy, 2010; 12(3): R93.
Navab Mohamad, Ruchala Piotr, Waring Alan J, Lehrer Robert I, Hama Susan, Hough Greg, Palgunachari Mayakonda N, Anantharamaiah G M, Fogelman Alan M   A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids Journal of lipid research, 2009; 50(8): 1538-47.
Charles-Schoeman Christina, Watanabe Junji, Lee Yuen Yin, Furst Daniel E, Amjadi Sogol, Elashoff David, Park Grace, McMahon Maureen, Paulus Harold E, Fogelman Alan M, Reddy Srinivasa T   Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis Arthritis and rheumatism, 2009; 60(10): 2870-9.
Van Lenten Brian J, Wagner Alan C, Anantharamaiah G M, Navab Mohamad, Reddy Srinivasa T, Buga Georgette M, Fogelman Alan M   Apolipoprotein A-I mimetic peptides Current atherosclerosis reports, 2009; 11(1): 52-7.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   HDL as a biomarker, potential therapeutic target, and therapy Diabetes, 2009; 58(12): 2711-7.
Watanabe Junji, Grijalva Victor, Hama Susan, Barbour Karen, Berger Franklin G, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein The Journal of biological chemistry, 2009; 284(27): 18292-301.
Vaziri Nosratola D, Moradi Hamid, Pahl Madeleine V, Fogelman Alan M, Navab Mohamad   In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide Kidney international, 2009; 76(4): 437-44.
Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Anantharamaiah G M, Fogelman Alan M   The role of dysfunctional HDL in atherosclerosis Journal of lipid research, 2009; 50 Suppl(4): S145-9.
Van Lenten Brian J, Wagner Alan C, Jung Chun-Ling, Ruchala Piotr, Waring Alan J, Lehrer Robert I, Watson Andrew D, Hama Susan, Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I Journal of lipid research, 2008; 49(11): 2302-11.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   Apo A-1 mimetic peptides as atheroprotective agents in murine models Current drug targets, 2008; 9(3): 204-9.
Buga Georgette M, Frank Joy S, Mottino Giuliano A, Hakhamian Ashkan, Narasimha Ajay, Watson Andrew D, Yekta Babak, Navab Mohamad, Reddy Srinivasa T, Anantharamaiah G M, Fogelman Alan M   D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet Journal of lipid research, 2008; 49(1): 192-205.
Cruz Daniel, Watson Andrew D, Miller Christopher S, Montoya Dennis, Ochoa Maria-Teresa, Sieling Peter A, Gutierrez Miguel A, Navab Mohamad, Reddy Srinivasa T, Witztum Joseph L, Fogelman Alan M, Rea Thomas H, Eisenberg David, Berliner Judith, Modlin Robert L   Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy The Journal of clinical investigation, 2008; 118(8): 2917-28.
Reddy Srinivasa T, Devarajan Asokan, Bourquard Noam, Shih Diana, Fogelman Alan M   Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? Current opinion in lipidology, 2008; 19(4): 405-8.
Van Lenten Brian J, Navab Mohamad, Anantharamaiah G M, Buga Georgette M, Reddy Srinivasa T, Fogelman Alan M   Multiple indications for anti-inflammatory apolipoprotein mimetic peptides Current opinion in investigational drugs (London, England : 2000), 2008; 9(11): 1157-62.
Bloedon Leanne T, Dunbar Richard, Duffy Danielle, Pinell-Salles Paula, Norris Robert, DeGroot Bruce J, Movva Rajesh, Navab Mohamad, Fogelman Alan M, Rader Daniel J   Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients Journal of lipid research, 2008; 49(6): 1344-52.
Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis Trends in cardiovascular medicine, 2008; 18(2): 61-6.
Charles-Schoeman Christina, Banquerigo Mona Lisa, Hama Susan, Navab Mohamad, Park Grace S, Van Lenten Brian J, Wagner Alan C, Fogelman Alan M, Brahn Ernest   Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis Clinical immunology (Orlando, Fla.), 2008; 127(2): 234-44.
Narasimha Ajay, Watanabe Junji, Lin James A, Hama Susan, Langenbach Robert, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors Prostaglandins & other lipid mediators, 2007; 84(1-2): 24-33.
Ng Carey J, Bourquard Noam, Hama Susan Y, Shih Diana, Grijalva Victor R, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice Arteriosclerosis, thrombosis, and vascular biology, 2007; 27(6): 1368-74.
Shih Diana M, Xia Yu-Rong, Wang Xu-Ping, Wang Susanna S, Bourquard Noam, Fogelman Alan M, Lusis Aldons J, Reddy Srinivasa T   Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice Circulation research, 2007; 100(8): 1200-7.
Watanabe Junji, Chou Katherine J, Liao James C, Miao Yunan, Meng Hsiang-Hui, Ge Helen, Grijalva Victor, Hama Susan, Kozak Kathy, Buga Georgette, Whitelegge Julian P, Lee Terry D, Farias-Eisner Robin, Navab Mohamad, Fogelman Alan M, Reddy Srinivasa T   Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis The Journal of biological chemistry, 2007; 282(32): 23698-707.
Charles-Schoeman Christina, Khanna Dinesh, Furst Daniel E, McMahon Maureen, Reddy Srinivasa T, Fogelman Alan M, Paulus Harold E, Park Grace S, Gong Timothy, Ansell Benjamin J   Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study The Journal of rheumatology, 2007; 34(7): 1459-64.
Van Lenten Brian J, Wagner Alan C, Navab Mohamad, Anantharamaiah G M, Hama Susan, Reddy Srinivasa T, Fogelman Alan M   Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits Journal of lipid research, 2007; 48(11): 2344-53.
Ansell Benjamin J, Fonarow Gregg C, Navab Mohamad, Fogelman Alan M   Modifying the anti-inflammatory effects of high-density lipoprotein Current atherosclerosis reports, 2007; 9(1): 57-63.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Buga Georgette M, Fogelman Alan M   Peptide Mimetics of Apolipoproteins Improve HDL Function Journal of clinical lipidology, 2007; 1(2): 142-7.
Anantharamaiah G M, Mishra Vinod K, Garber David W, Datta Geeta, Handattu Shaila P, Palgunachari Mayakonda N, Chaddha Manjula, Navab Mohamad, Reddy Srinivasa T, Segrest Jere P, Fogelman Alan M   Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Journal of lipid research, 2007; 48(9): 1915-23.
Ansell Benjamin J, Fonarow Gregg C, Fogelman Alan M   The paradox of dysfunctional high-density lipoprotein Current opinion in lipidology, 2007; 18(4): 427-34.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Fogelman Alan M   Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention Nature clinical practice. Cardiovascular medicine, 2006; 3(10): 540-7.
Buga Georgette M, Frank Joy S, Mottino Giuliano A, Hendizadeh Michael, Hakhamian Ashkan, Tillisch Jan H, Reddy Srinivasa T, Navab Mohamad, Anantharamaiah G M, Ignarro Louis J, Fogelman Alan M   D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet Journal of lipid research, 2006; 47(10): 2148-60.
Ansell Benjamin J, Fonarow Gregg C, Fogelman Alan M   High-density lipoprotein: is it always atheroprotective? Current atherosclerosis reports, 2006; 8(5): 405-11.
Navab Mohamad, Anantharamaiah Gattadahalli M, Reddy Srinivasa T, Van Lenten Brian J, Ansell Benjamin J, Fogelman Alan M   Mechanisms of disease: proatherogenic HDL--an evolving field Nature clinical practice. Endocrinology & metabolism, 2006; 2(9): 504-11.
Reddy Srinivasa T, Anantharamaiah G M, Navab Mohamad, Hama Susan, Hough Gregory, Grijalva Victor, Garber David W, Datta Geeta, Fogelman Alan M   Oral amphipathic peptides as therapeutic agents Expert opinion on investigational drugs, 2006; 15(1): 13-21.
Ng Carey J, Bourquard Noam, Grijalva Victor, Hama Susan, Shih Diana M, Navab Mohamad, Fogelman Alan M, Lusis Aldons J, Young Stephen, Reddy Srinivasa T   Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2 The Journal of biological chemistry, 2006; 281(40): 29491-500.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Datta Geeta, Garber David, Fogelman Alan M   Potential clinical utility of high-density lipoprotein-mimetic peptides Current opinion in lipidology, 2006; 17(4): 440-4.
McMahon Maureen, Grossman Jennifer, FitzGerald John, Dahlin-Lee Erika, Wallace Daniel J, Thong Bernard Y, Badsha Humeira, Kalunian Kenneth, Charles Christina, Navab Mohamad, Fogelman Alan M, Hahn Bevra H   Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis Arthritis and rheumatism, 2006; 54(8): 2541-9.
Anantharamaiah Gm, Navab Mohamad, Reddy Srinivasa T, Garber David W, Datta Geeta, Gupta Himanshu, White C Roger, Handattu Shaila P, Palgunachari Mayakonda N, Chaddha Manjula, Mishra Vinod K, Segrest Jere P, Fogelman Alan M   Synthetic peptides: managing lipid disorders Current opinion in lipidology, 2006; 17(3): 233-7.
Van Lenten Brian J, Reddy Srinivasa T, Navab Mohamad, Fogelman Alan M   Understanding changes in high density lipoproteins during the acute phase response Arteriosclerosis, thrombosis, and vascular biology, 2006; 26(8): 1687-8.
Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I Circulation research, 2005; 97(11): 1085-6.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Wagner Alan C, Hama Susan, Hough Greg, Bachini Eugene, Garber David W, Mishra Vinod K, Palgunachari Mayakonda N, Fogelman Alan M   An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice Arteriosclerosis, thrombosis, and vascular biology, 2005; 25(9): 1932-7.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Hama Susan, Hough Greg, Grijalva Victor R, Yu Nicholas, Ansell Benjamin J, Datta Geeta, Garber David W, Fogelman Alan M   Apolipoprotein A-I mimetic peptides Arteriosclerosis, thrombosis, and vascular biology, 2005; 25(7): 1325-31.
Navab Mohamad, Anantharamaiah G M, Hama Susan, Hough Greg, Reddy Srinivasa T, Frank Joy S, Garber David W, Handattu Shaila, Fogelman Alan M   D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice Arteriosclerosis, thrombosis, and vascular biology, 2005; 25(7): 1426-32.
Ansell Benjamin J, Watson Karol E, Fogelman Alan M, Navab Mohamad, Fonarow Gregg C   High-density lipoprotein function recent advances Journal of the American College of Cardiology, 2005; 46(10): 1792-8.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Hama Susan, Hough Greg, Frank Joy S, Grijalva Victor R, Ganesh Vannakambadi K, Mishra Vinod K, Palgunachari Mayakonda N, Fogelman Alan M   Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice Circulation research, 2005; 97(6): 524-32.
Navab Mohamad, Ananthramaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Ansell Benjamin J, Hama Susan, Hough Greg, Bachini Eugene, Grijalva Victor R, Wagner Alan C, Shaposhnik Zory, Fogelman Alan M   The double jeopardy of HDL Annals of medicine, 2005; 37(3): 173-8.
Navab Mohamad, Anantharamaiah G M, Fogelman Alan M   The role of high-density lipoprotein in inflammation Trends in cardiovascular medicine, 2005; 15(4): 158-61.
Fogelman Alan M   When pouring water on the fire makes it burn brighter Cell metabolism, 2005; 2(1): 6-8.
Ansell Benjamin J, Navab Mohamad, Watson Karol E, Fonarow Gregg C, Fogelman Alan M   Anti-inflammatory properties of HDL Reviews in endocrine & metabolic disorders, 2004; 5(4): 351-8.
Barter Philip J, Nicholls Stephen, Rye Kerry-Anne, Anantharamaiah G M, Navab Mohamad, Fogelman Alan M   Antiinflammatory properties of HDL Circulation research, 2004; 95(8): 764-72.
Navab Mohamad, Reddy Srinivasa T, Van Lenten Brian J, Fogelman Alan M   Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a) Arteriosclerosis, thrombosis, and vascular biology, 2004; 24(3): 392-3.
Datta Geeta, Epand Raquel F, Epand Richard M, Chaddha Manjula, Kirksey Matthew A, Garber David W, Lund-Katz Sissel, Phillips Michael C, Hama Susan, Navab Mohamad, Fogelman Alan M, Palgunachari Mayakonda N, Segrest Jere P, Anantharamaiah G M   Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity The Journal of biological chemistry, 2004; 279(25): 26509-17.
Van Lenten Brian J, Wagner Alan C, Navab Mohamad, Anantharamaiah G M, Hui Eric Ka-Wai, Nayak Debi P, Fogelman Alan M   D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes Circulation, 2004; 110(20): 3252-8.
Lusis Aldons J, Fogelman Alan M, Fonarow Gregg C   Genetic basis of atherosclerosis: part I: new genes and pathways Circulation, 2004; 110(13): 1868-73.
Lusis Aldons J, Fogelman Alan M, Fonarow Gregg C   Genetic basis of atherosclerosis: part II: clinical implications Circulation, 2004; 110(14): 2066-71.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Datta Geeta, Garber David, Fogelman Alan M   Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal Current opinion in lipidology, 2004; 15(6): 645-9.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Hama Susan, Hough Greg, Grijalva Victor R, Wagner Alan C, Frank Joy S, Datta Geeta, Garber David, Fogelman Alan M   Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice Circulation, 2004; 109(25): 3215-20.
Yan Daoguang, Navab Mohamad, Bruce Can, Fogelman Alan M, Jiang Xian-Cheng   PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity Journal of lipid research, 2004; 45(10): 1852-8.
Reddy Srinivasa T, Nguyen Julie T, Grijalva Victor, Hough Greg, Hama Susan, Navab Mohamad, Fogelman Alan M   Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models Arteriosclerosis, thrombosis, and vascular biology, 2004; 24(9): 1676-81.
Navab Mohamad, Ananthramaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Ansell Benjamin J, Fonarow Gregg C, Vahabzadeh Kambiz, Hama Susan, Hough Greg, Kamranpour Naeimeh, Berliner Judith A, Lusis Aldons J, Fogelman Alan M   The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL Journal of lipid research, 2004; 45(6): 993-1007.
Fogelman Alan M   When good cholesterol goes bad Nature medicine, 2004; 10(9): 902-3.
Castrillo Antonio, Joseph Sean B, Vaidya Sagar A, Haberland Margaret, Fogelman Alan M, Cheng Genhong, Tontonoz Peter   Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism Molecular cell, 2003; 12(4): 805-16.
Navab Mohamad, Anantharamaiah G M, Reddy Srinivasa T, Van Lenten Brian J, Hough Greg, Wagner Alan, Nakamura Kenta, Garber David W, Datta Geeta, Segrest Jere P, Hama Susan, Fogelman Alan M   Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis Current opinion in investigational drugs (London, England : 2000), 2003; 4(9): 1100-4.
Ansell Benjamin J, Navab Mohamad, Hama Susan, Kamranpour Naeimeh, Fonarow Gregg, Hough Greg, Rahmani Shirin, Mottahedeh Rachel, Dave Ravi, Reddy Srinivasa T, Fogelman Alan M   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation, 2003; 108(22): 2751-6.
Navab Mohamad, Hama Susan, Hough Greg, Fogelman Alan M   Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice Circulation, 2003; 108(14): 1735-9.
Reddy Srinivasa T, Hama Susan, Ng Carey, Grijalva Victor, Navab Mohamad, Fogelman Alan M   ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells Arteriosclerosis, thrombosis, and vascular biology, 2002; 22(11): 1877-83.
Reddy Srinivasa T, Grijalva Victor, Ng Carey, Hassan Khaled, Hama Susan, Mottahedeh Rachel, Wadleigh David J, Navab Mohamad, Fogelman Alan M   Identification of genes induced by oxidized phospholipids in human aortic endothelial cells Vascular pharmacology, 2002; 38(4): 211-8.
Van Lenten Brian J, Wagner Alan C, Anantharamaiah G M, Garber David W, Fishbein Michael C, Adhikary Lopa, Nayak Debi P, Hama Susan, Navab Mohamad, Fogelman Alan M   Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide Circulation, 2002; 106(9): 1127-32.
Navab Mohamad, Anantharamaiah G M, Hama Susan, Garber David W, Chaddha Manjula, Hough Greg, Lallone Roger, Fogelman Alan M   Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol Circulation, 2002; 105(3): 290-2.
Navab Mohamad, Hama Susan Y, Reddy Srinu T, Ng Carey J, Van Lenten Brian J, Laks Hillel, Fogelman Alan M, Ready Srinu T   Oxidized lipids as mediators of coronary heart disease Current opinion in lipidology, 2002; 13(4): 363-72.

Does this profile need updating? Contact Us